Product Information
SYNTHROID 112 MCG TABLET is a brand product labeled by AbbVie Inc., priced at $1.6604 per EA under NDC 00074929619. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
112 ug/1
Manufacturer
AbbVie Inc.NDC
00074929619
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021402On Market Since
7/24/2002
Pharmacological Classes
Price Statistics
The NADAC for SYNTHROID 112 MCG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 115.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6604 per EA |
|---|---|
| All-time high | $1.6639 (May 13, 2026) |
| All-time low | $0.7695 (Nov 28, 2013) |
| 52-week high | $1.6639 |
| 52-week low | $1.5842 |
| Median price | $1.2465 |
| Average price | $1.2426 |
| Largest weekly change | +9.8% (Jul 9, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SYNTHROID 112 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYNTHROID 112 MCG TABLET, manufactured by AbbVie Inc., is $1.6604 per EA (NDC 00074929619), effective Jun 24, 2026.
How has the price of SYNTHROID 112 MCG TABLET changed over time?
Over the history we have for it, the NADAC for SYNTHROID 112 MCG TABLET has risen 115.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SYNTHROID 112 MCG TABLET?
Since Nov 28, 2013, the NADAC for SYNTHROID 112 MCG TABLET has ranged from a low of $0.7695 (Nov 28, 2013) to a high of $1.6639 (May 13, 2026), with a median of $1.2465 per EA.
Are there cheaper alternatives to SYNTHROID 112 MCG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVOTHYROXINE 112 MCG TABLET, is $0.0616 per EA — about 96% below SYNTHROID 112 MCG TABLET.
Who manufactures SYNTHROID 112 MCG TABLET?
SYNTHROID 112 MCG TABLET (NDC 00074929619) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification